Piriformis Syndrome Market

Piriformis syndrome is a rare neuromuscular condition that is caused when the piriformis muscle compresses the sciatic nerve. The piriformis muscle is a flat, band-like muscle located in the buttock near the upper region of the hip joint. Piriformis syndrome mostly occurs in adults and can affect individuals from any field and activity levels. The common causes of piriformis syndrome are considered to be trauma, spasms, and overuse injury. Additionally, according to the National Center for Biotechnology Information (NCBI), the piriformis syndrome is more prevalent in patients with pain in the lower back.
Piriformis Syndrome Market contains market size and forecasts of Piriformis Syndrome in Global, including the following market information:
Global Piriformis Syndrome Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Piriformis Syndrome market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Medication Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Piriformis Syndrome include Novartis, Sanofi, Bayer, AstraZeneca, Teva Pharmaceuticals, Endo Pharmaceuticals, Omron Healthcare, DePuy Synthes and Miracle Stretch, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Piriformis Syndrome companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Piriformis Syndrome Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Piriformis Syndrome Market Segment Percentages, by Type, 2021 (%)
Medication
Physical Therapy
Others
Global Piriformis Syndrome Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Piriformis Syndrome Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Piriformis Syndrome Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Piriformis Syndrome Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Piriformis Syndrome revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Piriformis Syndrome revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Sanofi
Bayer
AstraZeneca
Teva Pharmaceuticals
Endo Pharmaceuticals
Omron Healthcare
DePuy Synthes
Miracle Stretch
Seirin Corporation
Nidd Valley Medical